Literature DB >> 18823300

Do thiazide diuretics alter the pharmacokinetics of metformin in patients with type 2 diabetes already established on metformin?

Eileen Y Y Sung, Michael Peter Moore, Helen Lunt, Matthew Doogue, Mei Zhang, Evan J Begg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18823300      PMCID： PMC2668094          DOI： 10.1111/j.1365-2125.2008.03302.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  4 in total

1.  Rapid and simple high-performance liquid chromatographic assay for the determination of metformin in human plasma and breast milk.

Authors:  Mei Zhang; Grant A Moore; Michael Lever; Sharon J Gardiner; Carl M J Kirkpatrick; Evan J Begg
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2002-01-05       Impact factor: 3.205

2.  Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors: 
Journal:  JAMA       Date:  2002-12-18       Impact factor: 56.272

Review 3.  New treatment guidelines for a patient with diabetes and hypertension.

Authors:  Carl Erik Mogensen
Journal:  J Hypertens Suppl       Date:  2003-03

4.  Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321
  4 in total
  2 in total

Review 1.  A Comprehensive Review of Drug-Drug Interactions with Metformin.

Authors:  Tore Bjerregaard Stage; Kim Brøsen; Mette Marie Hougaard Christensen
Journal:  Clin Pharmacokinet       Date:  2015-08       Impact factor: 6.447

2.  Safety, pharmacokinetics and pharmacodynamics of remogliflozin etabonate, a novel SGLT2 inhibitor, and metformin when co-administered in subjects with type 2 diabetes mellitus.

Authors:  Elizabeth K Hussey; Anita Kapur; Robin O'Connor-Semmes; Wenli Tao; Bryan Rafferty; Joseph W Polli; Charles D James; Robert L Dobbins
Journal:  BMC Pharmacol Toxicol       Date:  2013-04-30       Impact factor: 2.483
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.